AGORA INC-ADR (API)

US00851L1035 - ADR

2.52  +0.02 (+0.8%)

Fundamental Rating

3

Overall API gets a fundamental rating of 3 out of 10. We evaluated API against 276 industry peers in the Software industry. The financial health of API is average, but there are quite some concerns on its profitability. While showing a medium growth rate, API is valued expensive at the moment.



1

1. Profitability

1.1 Basic Checks

API had negative earnings in the past year.
In the past year API has reported a negative cash flow from operations.
API had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: API reported negative operating cash flow in multiple years.

1.2 Ratios

The Return On Assets of API (-12.93%) is comparable to the rest of the industry.
API has a Return On Equity of -14.42%. This is comparable to the rest of the industry: API outperforms 56.20% of its industry peers.
Industry RankSector Rank
ROA -12.93%
ROE -14.42%
ROIC N/A
ROA(3y)-11.88%
ROA(5y)-23.19%
ROE(3y)-13.1%
ROE(5y)-25.93%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 63.22%, API perfoms like the industry average, outperforming 47.08% of the companies in the same industry.
In the last couple of years the Gross Margin of API has declined.
API does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 63.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.76%
GM growth 5Y-2.28%

5

2. Health

2.1 Basic Checks

API does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, API has less shares outstanding
API has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, API has a worse debt to assets ratio.

2.2 Solvency

API has an Altman-Z score of 1.36. This is a bad value and indicates that API is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.36, API perfoms like the industry average, outperforming 42.70% of the companies in the same industry.
A Debt/Equity ratio of 0.02 indicates that API is not too dependend on debt financing.
API has a better Debt to Equity ratio (0.02) than 63.87% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 1.36
ROIC/WACCN/A
WACC8.17%

2.3 Liquidity

API has a Current Ratio of 4.60. This indicates that API is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 4.60, API belongs to the best of the industry, outperforming 86.13% of the companies in the same industry.
API has a Quick Ratio of 4.60. This indicates that API is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 4.60, API belongs to the top of the industry, outperforming 86.13% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.6
Quick Ratio 4.6

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 45.36% over the past year.
API shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -11.91%.
API shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 26.50% yearly.
EPS 1Y (TTM)45.36%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q95.24%
Revenue 1Y (TTM)-11.91%
Revenue growth 3Y1.94%
Revenue growth 5Y26.5%
Revenue growth Q2Q-10.17%

3.2 Future

API is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.70% yearly.
API is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.49% yearly.
EPS Next Y65.17%
EPS Next 2Y34%
EPS Next 3Y24.7%
EPS Next 5YN/A
Revenue Next Year3.74%
Revenue Next 2Y7.95%
Revenue Next 3Y9.87%
Revenue Next 5Y13.49%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

1

4. Valuation

4.1 Price/Earnings Ratio

API reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year API is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as API's earnings are expected to grow with 24.70% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34%
EPS Next 3Y24.7%

0

5. Dividend

5.1 Amount

No dividends for API!.
Industry RankSector Rank
Dividend Yield N/A

AGORA INC-ADR

NASDAQ:API (4/26/2024, 7:00:00 PM)

2.52

+0.02 (+0.8%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap232.34M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.93%
ROE -14.42%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 63.22%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 4.6
Quick Ratio 4.6
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)45.36%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y65.17%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-11.91%
Revenue growth 3Y1.94%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y